Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder-Reference-Cited by-同舟云学术

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder

Published:2017-06-12 Issue: Volume:8 Page:
ISSN:1664-0640
Container-title:Frontiers in Psychiatry
language:
Short-container-title:Front. Psychiatry

Author:

Svenningsson Per,Pålhagen Sven,Mathé Aleksander A.

Funder

Stockholms Läns Landsting

Medicinska Forskningsrådet

Publisher

Frontiers Media SA

Subject

Psychiatry and Mental health

Reference34 articles.

1. Parkinson’s disease;Kalia;Lancet,2015

2. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment;Chaudhuri;Lancet Neurol,2009

3. Depression in Parkinson disease – epidemiology, mechanisms and management;Aarsland;Nat Rev Neurol,2012

4. Elevated serotonin transporter binding in depressed patients with Parkinson’s disease: a preliminary PET study with [11C]DASB;Boileau;Mov Disord,2008

5. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures;Politis;Neurology,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay of human gastrointestinal microbiota metabolites: Short-chain fatty acids and their correlation with Parkinson’s disease;Medicine;2024-04-26

2. The association between migraine and Parkinson’s disease: a nationwide cohort study;Epidemiology and Health;2023-12-18

3. Cross talk about the role of Neuropeptide Y in CNS disorders and diseases;Neuropeptides;2023-12

4. Adolescent binge-like alcohol exposure dysregulates NPY and CGRP in rats: Behavioural and immunochemical evidence;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2023-04

5. A proteogenomic view of Parkinson’s disease causality and heterogeneity;npj Parkinson's Disease;2023-02-11